Pramirol
Pramirol contains Pramipexole, which is a non-ergoline dopamine agonist. It works by stimulating dopamine receptors in the brain, helping to reduce motor deficits in Parkinson's disease and reduce sensory-motor symptoms in Restless Legs Syndrome.
Dosage by Body Weight
Dosage must be titrated gradually starting from a low dose (typically 0.125 mg) and increased slowly over weeks under strict medical supervision. Take with or without food, but taking it with food may reduce nausea. Do not discontinue treatment abruptly.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established. |
| 5-7 kg | Not recommended | N/A | Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established. |
| 8-10 kg | Not recommended | N/A | Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established. |
| 11-15 kg | Not recommended | N/A | Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established. |
| 16-20 kg | Not recommended | N/A | Pramipexole is not indicated for pediatric use. Safety and efficacy in children have not been established. |
Formulation
Purpose
Used to treat signs and symptoms of Parkinson's disease and for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
Generic Name
PramipexoleScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.